title: PRND 3'UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease.
abstract: The etiology of behavioral and psychological symptoms of dementia (BPSD) is complex, including putative biological, psychological, social and environmental factors. Recent years have witnessed accumulation of data on the association between genetic factors and behavioral abnormalities in Alzheimer disease (AD). In this research paper, our aim is to evaluate the association between the APOE, CYP46, PRNP and PRND genes and the profile of neuropsychiatric symptoms in Polish subjects with AD and mild cognitive impairment (MCI). We studied 99 patients with AD and 48 subjects with MCI. The presence and profile of BPSD were evaluated at baseline and prospectively with the Neuropsychiatric Inventory (NPI). Patients were dichotomized into those having ever experienced a particular symptom and those who did not over the whole disease period. Genotyping was performed using previously described standard protocols. The prevalence of comorbid behavioral symptoms and the overall level of behavioral burden were significantly greater in AD compared with the MCI group. In AD patients, carrier status of the T allele of the 3'UTR (untranslated region) PRND polymorphism was associated with an increased cumulative behavioral load and an elevated risk for delusions, anxiety, agitation/aggression, apathy and irritability/emotional ability. Among MCI subjects, APOE ε4 carriers demonstrated a reduced risk for nighttime behavior change. No other statistically significant genotype-phenotype correlations were observed, including the APOE, CYP46 and PRNP genes. A precise estimation of the exact significance of particular polymorphisms in BPSD etiology requires future studies on large populations.
authors.affiliation: Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Lodz, Poland. marcin.flirski@umed.lodz.pl
authors.forename: Marcin
authors.initials: M
authors.lastname: Flirski
authors.forename: Monika
authors.initials: M
authors.lastname: Sieruta
authors.forename: Ewa
authors.initials: E
authors.lastname: Golańska
authors.forename: Iwona
authors.initials: I
authors.lastname: Kłoszewska
authors.forename: Paweł P
authors.initials: PP
authors.lastname: Liberski
authors.forename: Tomasz
authors.initials: T
authors.lastname: Sobów
mesh_terms: D020413:3' Untranslated Regions / Q000235:genetics*; D000368:Aged; D000544:Alzheimer Disease / Q000150:complications / Q000235:genetics*; D001526:Behavioral Symptoms / Q000150:complications / Q000235:genetics*; D060825:Cognitive Dysfunction / Q000150:complications / Q000235:genetics; D003710:Demography; D005260:Female; D058851:GPI-Linked Proteins / Q000235:genetics; D005787:Gene Frequency / Q000235:genetics; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011328:Prions / Q000235:genetics*
chemical_list: D020413:3' Untranslated Regions; D058851:GPI-Linked Proteins; C501125:PRND protein, human; D011328:Prions